Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune ...
UC San Diego leads a $25.8 million ARPA-H funded project to 3D bioprint patient-specific human livers, aiming to eliminate organ shortages.
Scientists suggest increasing what is understood about exocytosis could one day inform many fields of applied science.
Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.
Results reveal mechanism driving high blood pressure and point toward more precise therapies targeting communication between fat and blood vessels.
Following the closing, the Emeryville and Berkeley, CA, biologics manufacturing facilities will be transferred to Zydus.
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...
Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important.
In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.
Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific discovery. In an interview with GEN, he explained how Potato’s AI “scientist,” named Tater, recently replicated a main ...
In this GEN webinar, Guilherme Yamamoto, MD, PhD, and Sevana Yaghoubian will present a novel whole-exome assay for detecting high-confidence variants across multiple applications.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results